A 3-Year-Old Girl with Recurrent Infections and Autoimmunity due to a STAT1 Gain-of-Function Mutation: The Expanding Clinical Presentation of Primary Immunodeficiencies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A 3-Year-Old Girl with Recurrent Infections and Autoimmunity due to a STAT1 Gain-of-Function Mutation: The Expanding Clinical Presentation of Primary Immunodeficiencies
Authors
Keywords
-
Journal
Frontiers in Pediatrics
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-17
DOI
10.3389/fped.2017.00055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
- (2016) J. Toubiana et al. BLOOD
- Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature
- (2016) Christa S. Zerbe et al. CLINICAL INFECTIOUS DISEASES
- Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation
- (2016) Rotraut Mössner et al. CLINICAL INFECTIOUS DISEASES
- Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation
- (2016) Robin Kobbe et al. GENE
- Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1
- (2016) Safa Baris et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
- (2015) Eleanor Higgins et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015
- (2015) Capucine Picard et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation–polyendocrinopathy–enteropathy–X-linked–like syndrome
- (2013) Gulbu Uzel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis
- (2013) Elizabeth P. Sampaio et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis
- (2012) Anne Puel et al. Current Opinion in Allergy and Clinical Immunology
- Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes
- (2012) Stephanie Boisson-Dupuis et al. CURRENT OPINION IN IMMUNOLOGY
- Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects
- (2012) Karin R. Engelhardt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis
- (2012) Xiaowen Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autosomal-Dominant Chronic Mucocutaneous Candidiasis with STAT1-Mutation can be Complicated with Chronic Active Hepatitis and Hypothyroidism
- (2012) Tomohiro Hori et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Herpes in STAT1 gain-of-function mutation
- (2012) Beáta Tóth et al. LANCET
- Gain-of-function humanSTAT1mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
- (2011) Luyan Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- STAT1Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
- (2011) Frank L. van de Veerdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation